a WHO Regional Office for Europe , Copenhagen , Denmark.
Expert Rev Anti Infect Ther. 2019 Feb;17(2):75-78. doi: 10.1080/14787210.2018.1563482. Epub 2019 Jan 10.
This meeting was held from the 30 October to the 1 November 2018 in Almaty, Kazakhstan. The meeting brought together participants from 16 countries of central Asia, Caucasus, eastern Europe and expert speakers from western Europe and India. Participants discussed the analysis and use of data on antimicrobial medicines consumption, country experiences in enforcing legislation for prescription-only access to antibiotics, the role of primary health care (PHC) in tackling antimicrobial resistance (AMR), strategies to improving competencies of practitioners using evidence-based clinical protocols and public engagement in the responsible use of medicines. Moving toward prescription-only access to antibiotics requires that government involve, from the onset, different stakeholders, e.g. public, patients, practitioners, pharmacists and pharmaceutical industry in designing and applying policies that ensure access to antibiotics accompanied by measures that promote responsible use and limit excessive use.
本次会议于 2018 年 10 月 30 日至 11 月 1 日在哈萨克斯坦的阿拉木图举行。会议聚集了来自中亚、高加索、东欧 16 个国家的参与者以及来自西欧和印度的专家演讲者。与会者讨论了抗菌药物消费数据的分析和使用、各国在执行限制抗生素凭处方供应的立法方面的经验、初级卫生保健(PHC)在应对抗微生物药物耐药性(AMR)方面的作用、提高使用循证临床方案的执业人员能力的战略以及公众参与负责任地使用药物。实现抗生素凭处方供应需要政府从一开始就让不同的利益攸关方,如公众、患者、医生、药剂师和制药业参与到政策的制定和实施中,确保在提供抗生素的同时采取措施促进负责任的使用并限制过度使用。